Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8213145 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 26 Pages |
Abstract
In patients with p16-positive OPC in the CTXMAB+RT trial, CTX had lower efficacy than CDDP, with possible implications for treatment selection in this clinical setting.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Michela MD, Marta MD, Renzo MD, Luigi MD, Fabiola MD, Luciana MD, Marco MD, Liliana MD, Monica MD, Stefania MD, Pierluigi MD, Silvia MD, Paolo MD, Nadia MD, PhD, Luca MD, Loredana MD, Sandro MD, Salvatore MD, PhD, Stefano Maria MD, Prof.,